Holmium laser enucleation of the prostate (HoLEP) as same-day surgery: A safe and feasible option.

Autor: Blanco Fernández R; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain. Electronic address: rebecabfn@gmail.com., González Rodríguez I; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Fernández-Pello Montes S; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Sánchez Verdes P; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Miranda García P; Departamento de Anestesiología y Reanimación, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Suárez Sal PJ; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Alonso Calvar L; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain., Rodríguez Villamil L; Departamento de Urología, Hospital Universitario de Cabueñes, Gijón, Asturias, Spain.
Jazyk: English; Spanish; Castilian
Zdroj: Actas urologicas espanolas [Actas Urol Esp (Engl Ed)] 2023 Sep; Vol. 47 (7), pp. 457-461. Date of Electronic Publication: 2023 Jun 25.
DOI: 10.1016/j.acuroe.2023.05.006
Abstrakt: Objective: To study the feasibility of holmium laser enucleation (HoLEP) performed as a same-day surgery.
Material and Methods: Prospective observational study including 25 patients submitted to HoLEP. Patients were discharged the same day if they met the established criteria.
Results: The mean age of the patients was 65.1 years and prostate volume was 45.8cc. All patients were discharged the same day of surgery. The overall complication rate at 30 days was 12% (Clavien I 100%). The rate of re-hospitalization was 0%. Patient satisfaction rate with the day surgery pathway was 95%.
Conclusions: The initial analysis of our results suggests that outpatient HoLEP is a safe and effective alternative with low rate of complications. According to satisfaction rates, patients prefer the day surgery pathway for the performance of HoLEP.
(Copyright © 2023 The Authors. Published by Elsevier España, S.L.U. All rights reserved.)
Databáze: MEDLINE